K252169 is an FDA 510(k) clearance for the Access BNP II. This device is classified as a Test, Natriuretic Peptide (Class II - Special Controls, product code NBC).
Submitted by Beckman Coulter, Inc. (Chaska, US). The FDA issued a Cleared decision on March 24, 2026, 257 days after receiving the submission on July 10, 2025.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1117.
| 510(k) Number | K252169 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | July 10, 2025 |
| Decision Date | March 24, 2026 |
| Days to Decision | 257 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | NBC - Test, Natriuretic Peptide |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 862.1117 |